SimpsonSJrBlizzardLOtahalPVan der MeiITaylorB. Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis. J Neurol Neurosurg Psychiatry2011; in press.
2.
AscherioAMungerKL. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol2007; 61: 288–299.
3.
PonsonbyALvan der MeiIDwyerT. Exposure to infant siblings during early life and risk of multiple sclerosis. JAMA2005; 293: 463–469.
4.
WillerCJDymentDARischNJSadovnickADEbersGCCanadian Collaborative Study Group. Twin concordance and sibling recurrence rates in multiple sclerosis. Proc Natl Acad Sci U S A2003; 100: 12877–12882.
5.
O’GormanCFreemanSTaylorBVButzkuevenHfor the Australian and New Zealand MS Genetics Consortium (ANZgene), Broadley SA. Familial recurrence risks for multiple sclerosis in Australia. J Neurol Neurosurg Psychiatry2011; in press.
6.
HaflerDACompstonASawcerS. for the International Multiple Sclerosis Genetics Consortium. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med2007; 357: 851–862.
7.
Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene). Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet2009; 41: 824–828.
8.
FrankeAMcGovernDPBBarrettJC. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn’s disease susceptibility loci. Nat Genet2010; 42: 1118–1125.
9.
TaylorBVPearsonJFClarkeG. MS prevalence in New Zealand, an ethnically and latitudinally diverse country. Mult Scler2010; 16: 1422–1431.
10.
TaylorBVLucasRMDearK. Latitudinal variation in incidence and type of first central nervous system demyelinating events. Mult Scler2010; 16: 398–405.
11.
AscherioAMunchM. Epstein–Barr virus and multiple sclerosis. Epidemiology2000; 11: 220–224.
12.
GoldacreMJWottonCJSeagroattVYeatesD. Multiple sclerosis after infectious mononucleosis: record linkage study. J Epidemiol Community Health2004; 58: 1032–1035.
13.
PittasFPonsonbyALvan der MeiIA. Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis. J Neurol2009; 256: 577–585.
14.
van der MeiIAPonsonbyALDwyerT. Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study. BMJ2003; 327: 316.
15.
LucasRMPonsonbyALDearK. Sun exposure and vitamin D are independent risk factors for CNS demyelination. Neurology2011; 76: 540–548.
16.
AscherioAMungerKL. Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann Neurol200761: 504–513.
17.
van der MeiIAPonsonbyALTaylorBV. Human leukocyte antigen-DR15, low infant sibling exposure and multiple sclerosis: gene-environment interaction. Ann Neurol2010; 67: 261–265.
